Upright Healthcare Inc.
Update：2026/08/06
Industries
Main Industry
Health Care
Main Product/Service
Synmosa’s product portfolio is built on five proprietary technology platforms, including HFA metered-dose inhalers (MDI), nasal sprays, effervescent tablets, granules, and sex hormone formulations, addressing key therapeutic categories like asthma, hypert
Founded Year
2021
Unified Business No.
91062102
Status
Active
Number of Employees
0
Total Paid-in
Capital
231,913,200 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Synmosa Biopharma Corporation, founded in 1980, is a specialty pharmaceutical company engaged in agency, manufacturing, contract development (OEM), and R&D. With its core values of “Honesty, Credibility, Reliability, and Innovation,” Synmosa focuses on niche therapeutic areas such as cardiovascular, respiratory, urology, hormone therapy, and oncology.
